Bel-Gen

Belgen is a Turkish biotechnology and pharmaceutical company focused on the development and production of high-tech medical products, including vaccines and biological drugs. The company operates advanced R&D and manufacturing facilities designed to meet international GMP standards, aiming to reduce dependency on imported medical supplies in Turkey. Belgen's portfolio encompasses a range of therapeutic areas, with a particular emphasis on infectious diseases and oncology. By leveraging local expertise and strategic partnerships, the company seeks to provide affordable and accessible healthcare solutions both domestically and for export markets. Their activities include the production of sterile injectables and the development of biosimilars.